Incubation period of HIV-1 in perinatally infected children

AIDS

Volumn 12, Issue 7, 1998, Pages 759-766

  Pliner, Vadim ^a,h   Weedon, Jeremy ^a   Thomas, Pauline A ^b   Steketee, Richard W ^c   Abrams, Elaine J ^d   Lambert, Genevieve ^e   Greenberg, Barbara ^f   Bamji, Mahrukh ^g   Thea, Donald M ^a   Matheson, Pamela B ^a  

^a Med Hlth Res Assoc New York C   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d HARLEM HOSPITAL CENTER   (United States)

^e BRONX LEBANON HOSPITAL CENTER   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g METROPOLITAN HOSPITAL CENTER   (United States)

^h New York City Perinatal HIV T   (United States)

Author keywords

AIDS; Disease progression; HIV 1; Incubation period; Latency; Models projections; Pediatrics; Survival analysis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; ONSET AGE; PERINATAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL; UNITED STATES;

EID: 7144252530     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199807000-00012     Document Type: Article

References (37)

1. Auger I, Thomas P, De Gruttola V, et al.: Incubation periods for paediatric AIDS patients. Nature 1988, 336:575-577.
2. Commenges D, Alioum A, Lepage P, Van de Perre P, Msellati P, Dabis F: Estimating the incubation period of paediatric AIDS in Rwanda. AIDS 1992, 6:1515- 1520.
3. Scott GB, Hutto C, Makuch RW, et al.: Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989, 321:1791-1796.
4. Blanche S, Tardieu M, Duliege A, et al.: Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection: evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990, 144:1210-1215.
5. Italian Register for HIV Infection in Children: Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994, 343:191-195.
6. Persaud D, Chadwani S, Rigaud M, et al.: Delayed recognition of human immunodeficiency infection in preadolescent children. Pediatrics 1992, 90:688-691.
7. Tovo PA, de Martino M, Gabiano C, et al.: Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992, 339:1249-1253.
8. Bamji M, Thea DM, Weedon J, et al.: A prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. Pediatr Infect Dis J 1996, 15:891-898.
9. Blanche S, Newell M-L, Mayaux M-J, et al.: Morbidity and mortality in European children vertically infected by HIV-1: the French Pediatric HIV Infection Study group and European Collaborative Study. J Acquir Immune Defic Syndr 1997, 14:442-450.
10. Downs AM, Salamina G, Ancelle-Park RA: Incubation period of vertically acquired AIDS in Europe before widespread use of prophylactic therapies. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:297-304.
11. Barnhart HX, Caldwell B, Thomas P, et al.: Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996, 97:710- 716.
12. De Gruttola V, Tu XM, Pagano; P: Pediatric AIDS in New York City: estimating the distributions of infection, latency and reporting delay and projecting future incidence. J Am Stat Assoc 1992, 87:633-640.
13. MaWhinney S, Pagano M, Thomas P: Age at AIDS diagnosis for children with perinatally acquired HIV. J Acquir Immune Defic Syndr 1993, 6:1139-1144.
14. Mawhinney S, Pagano M: Distribution of latency period for perinatally acquired AIDS. Stat Med 1994, 13:2031-2042.
15. Dunn DT, Ades AE: Estimating the HIV vertical transmission rate and the pediatric AIDS incubation period from prospective data. J Am Stat Assoc 1996, 91:935-943.
16. Hoover DR, Saah AJ, Bacellar H, et al.: Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med 1993, 329:922-926.
17. Thea DM, Lambert G, Weedon J, et al.: Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. Pediatrics 1996, 97:59-64.
18. Stone VE, Seage III CR, Hertz T, Epstein AM: The relation between hospital experience and mortality for patients with AIDS. JAMA 1992, 268: 2655-2661.
19. Bennett CL, Adams J, Bennett RL, et al.: The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs Hospitals 1987-1991. J Acquir Immune Defic Syndr 1995, 8:373-378.
20. Thomas P, Weedon J, Krasinski K, et al.: Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infect Dis J 1994, 13:489-495.
21. Rogers MF, Ou CY, Rayfield M, et al.: Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. N Engl J Med 1989, 320:1649-1654.
22. Centers for Disease Control and Prevention: Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987, 36:225-235.
23. Centers for Disease Control and Prevention: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl):S1-S15.
24. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center: antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatr Infect Dis J 1993, 12:513-522.
25. Centers for Disease Control and Prevention: Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infection. MMWR 1989, 38:1-7.
26. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons Inc.; 1980.
27. SAS Institute Inc.: SAS/STAT User's Guide, Version 6. 4th Edn, Vol 2. Cary: SAS Institute Inc.; 1989.
28. Efron B: Censored data and the bootstrap. J Am Stat Assoc 1981, 76:312-319.
29. Akritas MG: Bootstrapping the Kaplan-Meier estimator. J Am Stat Assoc 1986, 81:1032-1038.
30. Efron B, Tibshirani RJ: An Introduction to the Bootstrap. New York: Chapman & Hall; 1993.
31. Oxtoby MJ: Vertically acquired HIV infection in the United States. In Pediatric AIDS. The Challenge of HIV Infection in Infants, Children, and Adolescents. 2nd edn. Edited by Pizzo PA, Wilfert CM. Baltimore: Williams & Wilkins; 1994:3-20.
32. Centers for Disease Control and Prevention: 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43:1-19.
33. Brookmeyer R, Gail MH: AIDS Epidemiology: A Quantitative Approach. New York: Oxford University Press; 1994.
34. Alcabes P, Muñoz A, Vlahov D, Friedland GH: Incubation period of human immunodeficiency virus. Epidemiol Rev 1993, 15:303-318.
35. Blanche S, Mayaux MJ, Rouzioux C, et al.: Relation of the course of HIV-1 infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994, 330:308-312.
36. Lambert G, Thea DM, Pliner V, et al.: Effect of maternal CD4+ count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. J Pediatr 1997, 130: 890-897.
37. Spencer T, Ogino M, Dankner W, Spector SA: Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. J Infect Dis 1994, 169:491-495.